ATI RN
ATI Pharmacology Exam Final Questions
Extract:
Question 1 of 5
A nurse is caring for a client who has prostate cancer. The nurse should expect the provider to prescribe which of the following medications for this client?
Correct Answer: B
Rationale: Leuprolide, a GnRH agonist, suppresses testosterone, slowing prostate cancer tissue growth.
Question 2 of 5
A nurse is educating a group of clients about the contraindications of warfarin therapy. Which of the following statements should the nurse include in the teaching?
Correct Answer: C
Rationale: Warfarin is teratogenic and increases fetal bleeding risk, making it contraindicated in pregnancy.
Question 3 of 5
A nurse is caring for a client who has deep vein thrombosis and has been on heparin continuous infusion for 5 days. The provider prescribes warfarin PO Without discontinuing the heparin. The client asks the nurse Why both anticoagulants are necessary. Which of the following Statements should the nurse make?
Correct Answer: A
Rationale: Warfarin has an onset of action of 4-5 days, requiring heparin to bridge the gap to prevent clot formation during this period.
Question 4 of 5
A nurse is caring for a client who has an infection and a prescription for gentamicin intermittent IV bolus every 8 hr. A peak and trough is required with the next dose. Which of the following actions should the nurse take to obtain an accurate gentamicin serum level?
Correct Answer: A
Rationale: Trough levels are drawn immediately before and peak levels 30-45 minutes after gentamicin administration.
Question 5 of 5
A nurse is caring for a client who has streptococcal pneumonia and a prescription for penicillin Gby intermittent IV bolus. 10 minutes into the infusion of the third dose, the client reports that the IV site itches and that he feels dizzy and short of breath. Which of the following actions should the nurse take first?
Correct Answer: B
Rationale: Stopping the infusion is the priority to prevent worsening anaphylaxis, indicated by itching, dizziness, and shortness of breath.